Pharmafile Logo
Pharmafocus logo
Advanced Search

ABPI to help pharma with digital communications

May 4, 2012
Medical Communications ABPI, Code breach, PMCPA, Shire, digital, pharma

The ABPI has set up a new group to help pharma with its online communications.  The UK industry body said …

News
GSK picture

GSK signs deal with academics

May 4, 2012
Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …

News

David Colin Thomé named as new Primary Care Commissioning chair

May 4, 2012
Business Services, Sales and Marketing NHS, PCC

Primary Care Commissioning (PCC) has appointed David Colin Thomé as chair with immediate effect.   Professor Thomé was until recently …

Appointment
Novartis image

Novartis to acquire Fougera for $1.5 billion

May 3, 2012
Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya

Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash.  Novartis’ generic unit Sandoz is conducting the …

News
Shell oil website

Roche and Novartis have best websites

May 3, 2012
Medical Communications Bowen Craggs & Co, Novartis, Pfizer, Roche, Shell, digital, web

A new survey of leading international companies has found Roche and Novartis have the best websites in the pharma sector.  …

News

GSK appoints two non-executive directors to its Board

May 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …

Appointment

Oxford BioTherapeutics appoints new chief operations officer

May 3, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics

Oxford BioTherapeutics (OBT) has appointed Dr Esteban Pombo-Villar as its new chief operations officer (COO). In this position he will …

Appointment

Pfizer enters Gaucher disease market

May 3, 2012
Sales and Marketing Cerezyme, Elelyso, Gaucher, Genzyme, Pfizer, Shire, Vpriv

Pfizer has gained FDA approval for its new Gaucher disease drug Elelyso.  Elelyso (taliglucerase alfa) is an enzyme replacement therapy …

News

Professional regulation – a DIY job?

May 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPD, GMC, Les Rose, drug discovery, regulation

What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …

Feature

Lilly invests in UK research base

May 2, 2012
Research and Development Elil Lilly, Erl Wood, neuroscience

Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …

News
Ian Read

Lipitor losses hit Pfizer

May 2, 2012
Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry

Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …

News

SHL to speak & exhibit at the PDA’s upcoming Prefilled Syringe Seminar in Japan

May 2, 2012
Manufacturing and Production auto injector, autoinjector, pda japan, prefilled syringe

SHL to speak & exhibit at the PDA’s upcoming Prefilled Syringe Seminar in Tokyo, Japan May 22nd-23rd 2012 Auto injectors …

News
Press release

Targacept cuts workforce

May 1, 2012
Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept

The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …

News

EMA eSubmission Gateway now live

May 1, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; ectd

Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …

News
Press release

Novartis will restart production at Lincoln plant in May

May 1, 2012
Manufacturing and Production FDA, GMP, Lincoln, Nebraska, Novartis, manufacturing

Novartis chief executive Joe Jimenez has said that production at the firm’s troubled consumer health plant in Lincoln, Nebraska, will …

News
FDA picture

FDA approves greener process for Januvia production

May 1, 2012
Manufacturing and Production Codexis, FDA, Januvia, Merck, manufacturing

The US Food and Drug Administration (FDA) has approved a new, more environmentally-friendly manufacturing process for Merck & Co’s diabetes …

News

Pharma manufacturing news in brief

May 1, 2012
Manufacturing and Production Aptar Pharma, Ark Therapeutics, Cambrex, Eckert & Ziegler, Granules India and Omkar Speciality Chemicals

Cambrex facility passes FDA inspection, low-cost inhaler launched by Aptar, plus updates from Eckert & Ziegler, Granules India and Omkar …

News

Contract research news in brief

May 1, 2012
Research and Development BML, Cetero Labs, Covance, Harlan and Chiltern, PRA

A round-up of recent developments in the contract research sector, featuring updates from PRA, Cetero Labs, Covance/BML, Harlan Labs CRS …

News

Actelion boosted by trial success

April 30, 2012
Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan

Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial.  The news comes after …

News
Votrient image

FDA approves GSK’s Votrient for new licence

April 30, 2012
Sales and Marketing Cancer, FDA Approval, GSK, Votrient

The FDA has approved GlaxoSmithKline’s cancer pill Votrient for the treatment of a rare group of cancers – but has …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026